MPN Research Foundation
David S. serves as Chief Scientific Officer at the MPN Research Foundation since January 2025, providing scientific leadership and collaborating with various stakeholders to advance the foundation's mission. An affiliate professor at the University of Washington's Department of Epidemiology since 1997, David also has a diverse background in biotechnology, having co-founded Monod Bio and served as a non-executive board member at Proteotype Diagnostics. David's extensive experience includes advisory roles at Achieve Partners and Phase Genomics, as well as previous leadership positions at Neoleukin Therapeutics. Educational qualifications include a PhD in Epidemiology and an MBA, alongside several other degrees from prestigious institutions.
This person is not in the org chart
This person is not in any teams
MPN Research Foundation
The mission of MPN Research Foundation is to stimulate original research in pursuit of new treatments — and eventually a cure — for the blood cancers essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF), known collectively as myeloproliferative neoplasms (MPN). Through a combination of MPN cancer research, advocacy and education, we bring together patients, researchers, and clinicians around the common goal of realizing new treatment options and ultimately, a cure for MPNs. In addition, MPN Research Foundation promotes collaboration in the scientific community to accelerate MPN research and serves as a powerful patient advocacy group for MPN patients and their families.